The San Diego Union-Tribune outlines Gen-Probe's potential in the diagnostics field, focusing on its $500 million bank account and a string of new deals that includes buying Tepnel and a renegotiated pact with Novartis. And analysts say the company is well positioned to weather the economic downturn. Report